Clinical Trial: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Solid Tumors
Study Type: INTERVENTIONAL
Official Title: A Phase 1/1b Open-label, Multicenter Clinical Study of MK-0472 as Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors.
Brief Summary:
The purpose of this study is to assess the efficacy, safety, and tolerability of MK-0472 administered as monotherapy and in combination with pembrolizumab (MK-3475) in participants with histologically or cytologically confirmed diagnosis of advanced/metastatic solid tumors.There is no primary hypothesis to be tested for this study.
Read more